High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Completed · Not applicable

Conditions studied: Breast Neoplasms

In brief

To evaluate the response rate and the response duration of high dose chemotherapy with autologous bone marrow transplantation as intensification following induction chemotherapy in metastatic breast cancer and to evaluate prospectively the subdivision of patients with metastatic breast cancer according to prognostic groups.

Key facts

Study ID

NCT00584428

Run by

University of Oklahoma

People needed

61

Starts

1992-06-01

Expected to finish

2002-03-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed diagnosis of breast cancer
• Age 18-70
• Breast cancer at first clinical evidence of metastatic disease
• Must have objectively measurable or evaluable disease or be in complete remission

You may not qualify if…

• Previous diagnosis of another invasive carcinaom within 10 years (except skin cancer)
• CNS involvement

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.